LOSS OF AMPLIFIED GENES BY POLY(ADP-RIBOSE) POLYMERASE INHIBITORS

被引:12
作者
NAGAO, M
NAKAYASU, M
AONUMA, S
SHIMA, H
SUGIMURA, T
机构
关键词
D O I
10.2307/3431185
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
A poly(ADP-ribose) polymerase inhibitor, benzamide (BA), was found to induce flat revertants of NIH 3T3 cells that had been transformed by human Ha-ras, rat Ki-ras, rat c-raf, and human ret-II. These genes had been amplified in original transformants, but they were completely eliminated by BA. Contrary to this, endogenous activated Ha-ras in a human bladder carcinoma cell line, T24, was not eliminated by BA. The gene loss seemed to be restricted to exogenous and/or amplified sequences. BA also eliminated the amplified c-myc gene in HL-60 cells, concomitant with differentiation into granulocytes. We demonstrated that the amplified c-myc gene was not present as episomes. It is probably present as double minutes or a homogeneously staining region. Dimethylsulfoxide also induced differentiation at a concentration that did not inhibit poly(ADP-ribose) polymerase. The cell lost the c-myc gene in association with this differentiation. The amplified c-myc gene in a colon adenocarcinoma cell line, COLO 320HSR, and the amplified mdr-1 gene in an adriamycin-resistant myelogenous leukemia cell line, K562/ADM, were not eliminated by BA. Various poly(ADP-ribose) polymerase inhibitors also eliminated human Ha-ras in the NIH 3T3 transformant and the c-myc gene in HL-60 cells.
引用
收藏
页码:169 / 174
页数:6
相关论文
共 23 条
[1]  
ALTHAUS FR, 1987, MOL BIOL BIOCH BIOPH, V37, P24
[2]  
BENJAMIN RC, 1980, J BIOL CHEM, V255, P493
[3]  
BURKLE A, 1987, CANCER RES, V47, P3632
[4]   MUTANT-CELLS DEFECTIVE IN POLY(ADP-RIBOSE) SYNTHESIS DUE TO STABLE ALTERATIONS IN ENZYME-ACTIVITY OR SUBSTRATE AVAILABILITY [J].
CHATTERJEE, S ;
HIRSCHLER, NV ;
PETZOLD, SJ ;
BERGER, SJ ;
BERGER, NA .
EXPERIMENTAL CELL RESEARCH, 1989, 184 (01) :1-15
[5]   (ADP-RIBOSE)N PARTICIPATES IN DNA EXCISION REPAIR [J].
DURKACZ, BW ;
OMIDIJI, O ;
GRAY, DA ;
SHALL, S .
NATURE, 1980, 283 (5747) :593-596
[6]   GENETIC ALTERATION OF THE C-MYC PROTOONCOGENE (MYC) IN HUMAN PRIMARY BREAST CARCINOMAS [J].
ESCOT, C ;
THEILLET, C ;
LIDEREAU, R ;
SPYRATOS, F ;
CHAMPEME, MH ;
GEST, J ;
CALLAHAN, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (13) :4834-4838
[7]   INDUCTION OF B-CELL DIFFERENTIATION ANTIGENS IN INTERFERON-TREATED OR PHORBOL ESTER-TREATED DAUDI CELLS IS IMPAIRED BY INHIBITORS OF ADP-RIBOSYLTRANSFERASE [J].
EXLEY, R ;
GORDON, J ;
CLEMENS, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (18) :6467-6470
[8]   DNA STRAND BREAKS AND ADP-RIBOSYL TRANSFERASE ACTIVATION DURING CELL-DIFFERENTIATION [J].
FARZANEH, F ;
ZALIN, R ;
BRILL, D ;
SHALL, S .
NATURE, 1982, 300 (5890) :362-366
[9]   MODULATION OF C-MYC EXPRESSION IN THE HL-60 CELL-LINE [J].
GROSSO, LE ;
PITOT, HC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 119 (02) :473-480
[10]   POLY(ADP-RIBOSE) METABOLISM APPEARS NORMAL IN EM9, A MUTAGEN-SENSITIVE MUTANT OF CHO CELLS [J].
IKEJIMA, M ;
BOHANNON, D ;
GILL, DM ;
THOMPSON, LH .
MUTATION RESEARCH, 1984, 128 (02) :213-220